Oligodendrocyte progenitor cells (OPCs) play a pivotal role in both health and disease within the central nervous system, with oligodendrocytes, arising from resident OPCs, being the main myelinating cell type. Disruption in OPC numbers can lead to various deleterious health defects. Numerous studies have described techniques for isolating OPCs to obtain a better understanding of this cell type and to open doors for potential treatments of injury and disease. However, the techniques used in the majority of these studies involve several steps and are time consuming, with current culture protocols using serum and embryonic or postnatal cortical tissue as a source of isolation. We present a primary culture method for the direct isolation of functional adult rat OPCs, identified by neuron-glial antigen 2 (NG2) and platelet derived growth factor receptor alpha (PDGFrα) expression, which can be obtained from the adult spinal cord. Our method uses a simple serum-free cocktail of 3 growth factors - FGF2, PDGFAA, and IGF-I, to expand adult rat OPCs in vitro to 96% purity. Cultured cells can be expanded for at least 10 passages with very little manipulation and without losing their phenotypic progenitor cell properties, as shown by immunocytochemistry and RT-PCR. Cultured adult rat OPCs also maintain their ability to differentiate into GalC positive cells when incubated with factors known to stimulate their differentiation. This new isolation method provides a new source of easily accessible adult stem cells and a powerful tool for their expansion in vitro for studies aimed at central nervous system repair.

Institute of Condensed Matter and Nanosciences Université catholique de Louvain 1348 Louvain la Neuve Belgium

Institute of Neuroscience Université catholique de Louvain Avenue Hippocrate B1 54 10 1200 Brussels Belgium

Integrated Center for Cell Therapy and Regenerative Medicine International Clinical Research Center St Anne's University Hospital Brno Pekařská 53 656 91 Brno Czech Republic

Louvain Drug Research Institute Advanced Drug Delivery and Biomaterials Université catholique de Louvain Avenue Mounier 73 B1 73 12 1200 Brussels Belgium

Zobrazit více v PubMed

Glia. 2003 Nov;44(2):153-65 PubMed

Cell Stem Cell. 2010 Oct 8;7(4):470-82 PubMed

J Neurosci. 2003 Jun 15;23(12):4967-74 PubMed

PLoS One. 2013 Jun 06;8(6):e65974 PubMed

Curr Protoc Stem Cell Biol. 2014 Nov 03;31:2D.17.1-15 PubMed

J Biol Chem. 1999 Jun 11;274(24):16831-7 PubMed

J Histochem Cytochem. 2009 May;57(5):405-23 PubMed

Cell Stem Cell. 2012 Apr 6;10(4):362-9 PubMed

Neuron. 1990 Oct;5(4):501-9 PubMed

Annu Rev Neurosci. 1995;18:159-92 PubMed

Glia. 2002 Oct;40(1):25-43 PubMed

J Neurosci. 2005 Aug 10;25(32):7470-9 PubMed

J Hematother Stem Cell Res. 2003 Dec;12(6):671-9 PubMed

Neuroscientist. 2003 Oct;9(5):379-97 PubMed

J Cell Physiol. 2011 Feb;226(2):322-30 PubMed

Nat Rev Genet. 2014 Feb;15(2):82-92 PubMed

Clin Neuroradiol. 2013 Dec;23 (4):309-14 PubMed

Int J Pharm. 2012 Jul 1;430(1-2):207-15 PubMed

Langmuir. 2009 Oct 6;25(19):11413-9 PubMed

Glia. 2005 Mar;49(4):542-54 PubMed

Glia. 2015 Apr;63(4):513-30 PubMed

Physiol Rev. 2001 Apr;81(2):871-927 PubMed

J Neurochem. 2007 Mar;100(6):1480-93 PubMed

J Cell Biol. 1992 Aug;118(4):889-900 PubMed

Stem Cells Dev. 2009 May;18(4):603-13 PubMed

J Neurosci. 2002 Oct 1;22(19):8574-85 PubMed

J Neurosci. 1996 Dec 1;16(23):7599-609 PubMed

Biochem Biophys Res Commun. 2013 May 17;434(4):779-84 PubMed

Int J Med Sci. 2013;10(5):522-31 PubMed

Neurosci Res. 2001 May;40(1):23-35 PubMed

Prog Histochem Cytochem. 2008;43(3):123-76 PubMed

Biomaterials. 2013 Apr;34(13):3381-9 PubMed

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6368-72 PubMed

Development. 1993 Jun;118(2):563-73 PubMed

Cold Spring Harb Protoc. 2013 Sep 01;2013(9):810-4 PubMed

Nature. 1988 Jun 9;333(6173):562-5 PubMed

J Neurosci Res. 1988 Oct-Dec;21(2-4):199-209 PubMed

Arch Biochem Biophys. 1991 Jun;287(2):297-304 PubMed

Science. 1997 Apr 4;276(5309):66-71 PubMed

Adv Biomed Res. 2015 Feb 17;4:53 PubMed

Pharm Res. 2002 Jun;19(6):875-80 PubMed

Glia. 2015 Aug;63(8):1350-6 PubMed

Ann N Y Acad Sci. 1991;638:378-86 PubMed

J Neurotrauma. 2000 Jan;17(1):1-17 PubMed

J Cell Biol. 2000 Mar 6;148(5):971-84 PubMed

Curr Opin Neurobiol. 1998 Oct;8(5):671-6 PubMed

PLoS One. 2011;6(11):e27079 PubMed

Mol Cell Neurosci. 1996 Apr;7(4):263-75 PubMed

Int J Pharm. 2002 Aug 28;243(1-2):135-46 PubMed

Neuroscientist. 2007 Feb;13(1):62-76 PubMed

Development. 1994 May;120(5):1097-108 PubMed

Mol Cell Neurosci. 2002 May;20(1):30-42 PubMed

Neurosurgery. 2013 Jan;72(1):118-29; discussion 129 PubMed

J Neurosci. 2000 Feb 1;20(3):1085-95 PubMed

Int J Pharm. 2009 Sep 11;379(2):201-9 PubMed

PLoS One. 2013;8(2):e55149 PubMed

Childs Nerv Syst. 2015 May;31(5):759-63 PubMed

Eur J Neurosci. 2014 Oct;40(7):3111-9 PubMed

Curr Biol. 2015 Sep 21;25(18):2411-6 PubMed

Brain Res. 2008 May 13;1209:105-14 PubMed

Mol Cell Neurosci. 2000 Mar;15(3):314-29 PubMed

J Neurosci Res. 1997 Oct 15;50(2):229-37 PubMed

Am J Pathol. 2004 Dec;165(6):2167-75 PubMed

J Histochem Cytochem. 2007 Mar;55(3):209-22 PubMed

J Neurosci. 2001 Sep 15;21(18):7194-202 PubMed

Glia. 1999 Jun;26(4):291-301 PubMed

PLoS One. 2011;6(11):e27393 PubMed

Prog Neurobiol. 2004 Feb;72(2):111-27 PubMed

Int J Pharm. 2008 Mar 20;352(1-2):1-4 PubMed

Exp Neurol. 2008 Aug;212(2):458-67 PubMed

J Neurosci. 1996 Dec 15;16(24):7981-94 PubMed

J Control Release. 2016 Sep 28;238:253-262 PubMed